Works matching IS 03656233 AND DT 2023 AND VI 356 AND IP 7
Results: 16
Editorial Board: Arch Pharm (7/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202370014
- Publication type:
- Article
Review of β‐carboline and its derivatives as selective MAO‐A inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202300091
- By:
- Publication type:
- Article
Cover Picture: Arch Pharm (7/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202370013
- Publication type:
- Article
Novel substituted 1,8‐naphthyridines: Design, synthesis, radiolabeling, and evaluation of apoptosis and topoisomerase II inhibition.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202300035
- By:
- Publication type:
- Article
Investigation of selective retinoic acid receptor alpha antagonist ER‐50891 and related analogs for male contraception.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202300031
- By:
- Publication type:
- Article
Tetrahydroquinazoline N‐oxide derivatives inhibit reproduction of tick‐borne and mosquito‐borne flaviviruses.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202300027
- By:
- Publication type:
- Article
Selective noncovalent proteasome inhibiting activity of trifluoromethyl‐containing gem‐quaternary aziridines.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202300174
- By:
- Publication type:
- Article
A review: Biological activities of novel cyanopyridine derivatives.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202300067
- By:
- Publication type:
- Article
Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202300137
- By:
- Publication type:
- Article
Nanoemulsions for increased penetrability and sustained release of leishmanicidal compounds.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202300108
- By:
- Publication type:
- Article
Imidazopyridine chalcones as potent anticancer agents: Synthesis, single‐crystal X‐ray, docking, DFT and SAR studies.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202300106
- By:
- Publication type:
- Article
Synthesis and antimicrobial testing of 5‐fluorouracil derivatives.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202300103
- By:
- Publication type:
- Article
Synthesis, structure–activity relationship, and biological evaluation of quinolines for development of anticancer agents.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202200673
- By:
- Publication type:
- Article
Synthesis and structure–activity relationships of USP48 deubiquitinylase inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202200661
- By:
- Publication type:
- Article
Development of heterodimeric estrogen receptor alpha antagonists to target simultaneously the ligand and coactivator binding site.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202200638
- By:
- Publication type:
- Article
Introduction to artificial intelligence and deep learning using interactive electronic programming notebooks.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 7, p. 1, doi. 10.1002/ardp.202200628
- By:
- Publication type:
- Article